Comparing the efficacy of dual Platelet-Rich Plasma (PRP) and Hyaluronic Acid (HA) therapy with PRP-alone therapy in the treatment of knee osteoarthritis: a systematic review and meta-analysis

Journal of Experimental Orthopaedics - Tập 8 Số 1 - 2021
Angeline Ai Ling Aw1, Jun Jie Leeu1, Xinyu Tao1, Hamid Rahmatullah Bin Abd Razak2,3
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
2Department of Orthopaedic Surgery, Sengkang General Hospital, Singapore, Singapore
3SingHealth Duke-NUS Musculoskeletal Sciences Academic Clinical Programme, Singapore, Singapore

Tóm tắt

Abstract Purpose

This study aims to compare the efficacy of a dual therapy of Platelet-Rich Plasma (PRP) and Hyaluronic Acid (HA) compared with PRP-alone therapy in the treatment of knee osteoarthritis (KOA).

Methods

PubMed, Embase, CINAHL, SCOPUS, Cochrane Library, grey literature and bibliographic references were searched from inception to January 2021. Only randomized controlled trials (RCTs) and retrospective cohort studies comparing the effect of PRP and HA versus PRP-alone therapy for KOA were included. Literature retrieval and data extraction were conducted by three independent reviewers. Pooled analysis of Visual Analogue Scale (VAS), Western Ontario and McMaster Universities Arthritis Index (WOMAC), International Knee Documentation Committee (IKDC) scores and adverse events were conducted.

Results

Ten studies (7 RCTs, 3 cohort studies) involving 983 patients were covered. Dual PRP and HA therapy resulted in significant reduction in VAS compared to PRP-alone therapy at 4–6 weeks (P < 0.00001) and 12 months (P < 0.00001). Dual therapy resulted in better WOMAC score improvement at 3 (P = 0.02), 6 (P = 0.05) and 12 months (P < 0.0001) compared to PRP-alone therapy. The IKDC score for dual therapy was also higher at 6 months compared to PRP-alone therapy (P = 0.007). Regarding adverse events, dual therapy was generally safer than PRP-alone therapy (P = 0.02).

Conclusion

While there is a paucity of large high-quality Level I studies, current best evidence suggests that dual therapy with PRP and HA for KOA may be effective at providing pain relief and improvement in function up to 1 year following administration.

Level of evidence

II.

Từ khóa


Tài liệu tham khảo

Abate M, Verna S, Schiavone C, Di Gregorio P, Salini V (2015) Efficacy and safety profile of a compound composed of platelet-rich plasma and hyaluronic acid in the treatment for knee osteoarthritis (preliminary results). Eur J Orthop Surg Traumatol 25:1321–1326

Anandacoomarasamy A, March L (2010) Current evidence for osteoarthritis treatments. Ther Adv Musculoskelet Dis 2:17–28

Andia I, Abate M (2014) Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association? Expert Opin Biol Ther 14:635–649

Altman R, Bedi A, Manjoo A, Niazi F, Shaw P, Mease P (2018) Anti-inflammatory effects of intra-articular hyaluronic acid: a systematic review. Cartilage 10:43–52

Alves R, Grimalt R (2017) A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord 4:18–24

Baria M, Vasileff W, Borchers J, DiBartola A, Flanigan D, Plunkett E, Magnussen R (2021) Treating knee osteoarthritis with platelet-rich plasma and hyaluronic acid combination therapy: a systematic review. Am J Sports Med 363546521998010

Campbell K, Saltzman B, Mascarenhas R, Khair M, Verma N, Bach B, Cole B (2015) Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping Meta-analyses. Arthroscopy 31:2213–2221

Chen W, Lo W, Hsu W, Wei H, Liu H, Lee C, Tina Chen S, Shieh Y, Williams D, Deng W (2014) Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials 35:9599–9607

Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H (2020) Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29-30:100587

Daheshia M, Yao J (2008) The interleukin 1β pathway in the pathogenesis of osteoarthritis. J Rheumatol 35:2306–2312

Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author′s perspective. J Cutan Aesthet Surg 7:189

Ding Q, Lv S, Shen X, Tong P (2017) A prospective randomized controlled study on platelet-rich plasma (PRP) combined with sodium hyaluronate (HA) intra-articular injection in the treatment of knee osteoarthritis. Shanghai Med Pharmaceut J 38(5):25–28

Dohan Ehrenfest David M (2014) Classification of platelet concentrates (platelet-rich plasma-PRP, platelet-rich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J 4(1):3–9

Fadadu P, Mazzola A, Hunter C, Davis T (2019) Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization. Reg Anesthesia Pain Med 44:652–659

Filardo G, Di Matteo B, Di Martino A, Merli M, Cenacchi A, Fornasari P, Marcacci M, Kon E (2015) Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation. Am J Sports Med 43:1575–1582

Filard G, Kon E, Di Martino A, Di Matteo B, Merli M, Cenacchi A, Fornasari P, Marcacci (2012) Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord 13(1):229

Guo Y, Yu H, Yong M et al (2018) Treatment of knee osteoarthritis with mixture of platelet-rich-plasma plus hyaluronic acid. Chin J Joint Surg (Electronic Edition) 12:874–878

Guo Y, Yu H, Yuan L (2016) Treatment of knee osteoarthritis with platelet-rich plasma plus hyaluronic acid in comparison with platelet-rich plasma only. Int J Clin Exp Med 9(6):12085–12090

Hermans J, Bierma-Zeinstra S, Bos P, Niesten D, Verhaar J, Reijman M (2019) The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial. BMC Musculoskelet Disord 20:196

Hsu H. Knee Osteoarthritis. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK507884/. Published June 29, 2020. Accessed 15 Jan 2021

Jacob G, Shetty V, Shetty S (2017) A study assessing intra-articular PRP vs PRP with HMW HA vs PRP with LMW HA in early knee osteoarthritis. J Arthrosc Jt Surg 4:65–71

Ke C, Zhang R, Xue J (2016) Clinical efficacy of autologous platelet-rich plasma combined with intra-articular hyaluronic acid injection for knee osteoarthritis. Chin Gen Pract 14:1810–1812

Kennedy M, Whitney K, Evans T, LaPrade R (2018) Platelet-rich plasma and cartilage repair. Curr Rev Musculoskelet Med 11:573–582

Kon E, Di Matteo B, Delgado D, Cole B, Dorotei A, Dragoo J, Filardo G, Fortier L, Giuffrida A, Jo C, Magalon J, Malanga G, Mishra A, Nakamura N, Rodeo S, Sampson S, Sánchez M (2020) Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system. Expert Opin Biol Ther 20:1447–1460

Lana H, Weglein A, Sampson S, Vicente E, Huber S, Souza C, Ambach M, Vincent H, Urban-paffaro A, Onodera C, Annichino-bizzacchi J, Santana M, Belangero W (2016) Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med 12:69–78

Mautner K, Malanga G, Smith J, Shiple B, Ibrahim V, Sampson S, Bowen J (2015) A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM&R 7:S53–S59

Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, Chalhoub A, Khalil C, Alaaeddine N (2017) Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Exp Cell Res 352:146–156

Palco M, Fenga D, Basile GC, Rizzo P, Cavalieri B, Leonetti D et al (2021) Platelet-rich plasma combined WITH hyaluronic ACID versus leucocyte and platelet-rich plasma in the conservative treatment of knee osteoarthritis. A retrospective study. Medicina 57(3):232

Patel S, Dhillon M, Aggarwal S, Marwaha N, Jain A (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis. Am J Sports Med 41:356–364

Rabi’u M, Aliyu D (2019) Effect of addition of hyaluronic acid on platelet rich plasma in treatment of chronic osteoarthritis. EAS J Orthop Physiother 1:63–67

Rahman M, Islam S, Hossain M, Arefin M, Islam M, Begum S, Shompa S, Akhtaruzzaman A (2019) Effects of platelet rich plasma in combination with hyaluronic acid in the treatment of primary knee osteoarthritis. J Natl Inst Neurosci Bangladesh 5(2):137–142

Rodeo S (2019) The need for minimum reporting standards for studies of “biologics” in sports medicine. Am J Sports Med 47(11):2531–2532

Rossi L, Murray I, Chu C, Muschler G, Rodeo S, Piuzzi N (2019) Classification systems for platelet-rich plasma. Bone Joint J 101-B:891–896

Sánchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, Albillos J, Gárate R, Aguirre J, Padilla S, Orive G, Anitua E (2012) A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 28:1070–1078

Smith P (2016) Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis. Am J Sports Med 44:884–891

Sowers M, Karvonen-Gutierrez C (2010) The evolving role of obesity in knee osteoarthritis. Curr Opin Rheumatol 22:533–537

Sun SF, Lin GC, Hsu C et al (2021) Comparing efficacy of intraarticular single crosslinked Hyaluronan (HYAJOINT Plus) and platelet-rich plasma (PRP) versus PRP alone for treating knee osteoarthritis. Sci Rep 11:140

Sundman E, Cole B, Karas V, Della Valle C, Tetreault M, Mohammed H, Fortier L (2013) The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 42:35–41

Tamer T (2013) Hyaluronan and synovial joint: function, distribution and healing. Interdiscip Toxicol 6:111–125

Vaquerizo V, Plasencia M, Arribas I, Seijas R, Padoilla S, Orive G, Anitua E (2013) Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy 29:1635–1643

Xu Z, He Z, Shu L, Li X, Ma M, Ye C (2021) Intra-articular platelet-rich plasma combined with hyaluronic acid injection for knee osteoarthritis is superior to platelet-rich plasma or hyaluronic acid alone in inhibiting inflammation and improving pain and function. Arthroscopy: J Arthrosc Related Surg 37(3):903–915

Yu W, Xu P, Huang G, Liu L (2018) Clinical therapy of hyaluronic acid combined with platelet-rich plasma for the treatment of knee osteoarthritis. Exp Ther Med 16(3):2119–2125

Zhang Y, Jordan J (2010) Epidemiology of osteoarthritis. Clin Geriatr Med 26:355–369

Zhao J, Huang H, Liang G, Zeng L, Yang W, Liu J (2020) Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord 21(1):224

Zhao X (2018) Clinical effect of sodium hyaluronate injection combined with autologous platelet rich plasma injection for knee osteoarthritis. Clin Res Pract 3(25):27–28